➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Patent: 7,818,100

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,818,100
Title:System and method for optimized runway exiting
Abstract: Methods and apparatus are provided for optimizing runway exiting. Prior to landing, the pilot may choose to input one or more new landing parameters. Then, based on current landing parameters (e.g., any new landing parameter(s) and remaining default landing parameters) and the aircraft performance parameters, predicted landing performance can be updated and indicia of the updated predicted landing performance can be displayed to the pilot on an updated airport map and display. The updated predicted landing performance can include, among other things, a display of AUTOBRAKE landing performance. When no further changes to the current landing parameters are desired, the automatic braking system can be set to provide dynamic braking to slow the aircraft to a selected velocity at a selected position on a particular runway.
Inventor(s): Goodman; William L. (Coupeville, WA), Imrich; Thomas (Mercer Island, WA)
Assignee: The Boeing Company (Chicago, IL)
Application Number:11/777,351
Patent Claims:see list of patent claims

Details for Patent 7,818,100

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial The Boeing Company (Chicago, IL) 2027-04-03 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.